BEIJING, July 7 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People’s Republic of China (the "PRC"), today announced it will present at the Global Hunter Securities 2010 China Conference held July 11-13, 2010 in San Francisco, California. Presentation details are noted below.
Date: Monday, July 12, 2010
Time: 3:30 PM
Location: The St. Regis Hotel, San Francisco, CA
Lotus will also be available for one-on-one meetings with investors on the 12th and 13th. Investors interested in attending the event should contact Global Hunter Securities. For more information about the conference, please visit http://www.ghsecurities.com/ .
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )
Lotus Pharmaceuticals, Inc. is a growing developer and producer of drugs and a licensed national seller of pharmaceutical items in the PRC. Lotus operates its business through its two controlled entities: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus’ current drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. Liang Fang sells drugs directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces of the PRC.
For more information, please contact:
Lotus Pharmaceuticals, Inc.
Yan ZENG, CFO
Tel: +86-10-6389-9868
Email: zy@lotuspharma.com